Preoperative factors of apathy in subthalamic stimulated Parkinson disease: a PET study.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 25253750.
- Also identified by DOI 10.1212/WNL.0000000000000941.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The current literature provides discrepant results regarding preoperative sociodemographic and clinical factors, and no information about preoperative cerebral metabolic patterns associated with apathy after subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson disease. To resolve this issue, we set out to identify preoperative metabolic patterns and sociodemographic and clinical factors associated with increased apathy after STN-DBS. Forty-four patients with Parkinson disease were enrolled in this study. They all underwent STN-DBS. Metabolic activity was assessed with F-18 fluorodeoxyglucose PET 3 months before surgery. Apathy was assessed on the Apathy Evaluation Scale 3 months before and after STN-DBS. We controlled for preoperative age, levodopa therapy, and overall cognitive functions. Increased apathy after STN-DBS was significantly associated with reduced preoperative metabolism within the right ventral striatum. None of the sociodemographic and clinical variables tested were associated with apathy after STN-DBS. Preoperative PET, but not sociodemographic or clinical factors, is associated with apathy after STN-DBS.
Medical subject headings
- Apathy
- Deep Brain Stimulation
- Parkinson Disease
- Positron-Emission Tomography
- Preoperative Period
- Subthalamic Nucleus
- Ventral Striatum